Effect of the disclosure of MS diagnosis on anxiety, mood and quality of life of patients: a prospective study
International Journal of Clinical Practice,  Clinical Article

Mattarozzi K et al. – This first prospective study provides objective data showing that early disclosure of multiple sclerosis diagnosis improves both the patient's quality of life and psychological well–being. In addition, the results seem to suggest that clinically isolated syndrome disclosure does not lead to the same favourable effects.

Methods
  • Eligible participants were all patients referred for the first time to the Neurological Unit who had manifested symptoms suggestive of MS for no more than 6 months.
  • All patients were evaluated for
    • QoL (SEIQoL and MS-QoL54).
    • Anxiety (STAI) and Depression (CMDI) on study inclusion (T0), 30 days after diagnosis disclosure (T30), and after 1 (T1y) and 2 (T2y) years' follow-up.

Results
  • Two hundred and twenty-nine patients were enrolled; 93 of these were unaware of their diagnosis.
  • Patients who already knew their diagnosis (100 with CIS and 22 with MS) were excluded from the main analyses and used to perform control analyses.
  • At the end of the screening, an MS diagnosis was disclosed to 18 of the 93 patients, whereas a CIS diagnosis was disclosed to 62 patients (12 patients received a diagnosis other than MS or CIS).
  • Thirty days after diagnosis disclosure, irrespective of the diagnosis disclosed, both QoL and Anxiety and Depression were significantly rated as better compared to the start of screening, (ps < 0.03), and this improvement remained stable over the two annual follow-ups.
  • However, as suggested by a significant `Time' × `Diagnosis' interaction with regard to both QoL and Anxiety and Depression (ps < 0.02), the effect of the disclosure in the short term differed depending on CIS or MS diagnosis.
  • Specifically, on MSQoL, which is a health-related QoL scale, the authors found a statically significant improvement, immediately after the diagnosis disclosure, in both the MS and CIS groups (ps < 0.01).
  • Differently, on SEIQoL, which is a non health-related QoL measure, and on the anxiety scale, the authors observed a statistically significant improvement only in the group which received a MS diagnosis (ps < 0.03).

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Psychiatry

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Psychiatry Articles

1 Zolpidem and the risk of Parkinson's disease: A nationwide population-based study Journal of Psychiatric Research, August 1, 2014    Clinical Article

2 The effect of bupropion XL and escitalopram on memory and functional outcomes in adults with major depressive disorder: Results from a randomized controlled trial Psychiatry Research, August 5, 2014    Clinical Article

3 Prazosin in the treatment of PTSD Journal of Psychiatric Practice, July 25, 2014    Review Article

4 Curcumin for the treatment of major depression: A randomised, double-blind, placebo controlled study Journal of Affective Disorders, July 17, 2014    Clinical Article

5 Risk of suicidal behavior with antidepressants in bipolar and unipolar disorders The Journal of Clinical Psychiatry, August 4, 2014    Clinical Article

6 Association of testosterone levels and future suicide attempts in females with bipolar disorder Journal of Affective Disorders, July 17, 2014    Clinical Article

7 The relationship between serum BDNF level and depression Full Text Neuropsychiatric Disease and Treatment, August 14, 2014    Free full text    Clinical Article

8 The effect of desvenlafaxine 50 mg/day on a subpopulation of anxious/depressed patients: a pooled analysis of seven randomized, placebo-controlled studies Human Psychopharmacology: Clinical and Experimental, August 20, 2014    Clinical Article

9 Association between early temperament and depression at 18 years Depression and Anxiety, August 18, 2014    Clinical Article

10 Levomilnacipran: A new serotonin-norepinephrine reuptake inhibitor for the treatment of major depressive disorder Annals of Pharmacotherapy, July 28, 2014    Review Article    Clinical Article

11 Mild traumatic brain injury and ADHD: A systematic review of the literature and meta-analysis Journal of Attention Disorders, August 25, 2014    Evidence Based Medicine

12 Treatment response and remission in a double-blind, randomized, head-to-head study of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit hyperactivity disorder CNS Drugs, August 11, 2014    Clinical Article

13 A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin–noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine Human Psychopharmacology: Clinical and Experimental, August 22, 2014    Clinical Article

14 Adding psychotherapy to antidepressant medication in depression and anxiety disorders: A meta-analysis FOCUS, August 26, 2014    Evidence Based Medicine    Clinical Article

15 Oral contraceptive use and psychiatric disorders in a nationally representative sample of women Archives of Women's Mental Health, August 29, 2014    Clinical Article

16 Efficacy of vilazodone on anxiety symptoms in patients with major depressive disorder International Clinical Psychopharmacology, July 3, 2014    Clinical Article

17 Associations between mood, anxiety or substance use disorders and inflammatory markers after adjustment for multiple covariates in a population-based study Journal of Psychiatric Research, August 7, 2014    Clinical Article

18 Efficacy of atomoxetine in adults with attention deficit hyperactivity disorder: An integrated analysis of the complete database of multicenter placebo-controlled trials Journal of Psychopharmacology, July 31, 2014    Clinical Article

19 The impact of second-generation antipsychotic adherence on positive and negative symptoms in recent-onset schizophrenia Schizophrenia Research, August 15, 2014    Clinical Article

20 Improvement in suicidal ideation after ketamine infusion: Relationship to reductions in depression and anxiety Journal of Psychiatric Research, August 21, 2014    Clinical Article

Indexed Journals in Psychiatry : Current Psychiatry, Bipolar Disorders, American Journal of Psychiatry, Addictionmore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close